LY2275796 in Advanced Cancer

NCT00903708 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: LY2275796

Sponsor

M.D. Anderson Cancer Center